{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:11:46Z","timestamp":1789989106620,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":3567,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Influenza A virus causes considerable morbidity and mortality largely because of a lack of effective antiviral drugs. Viral neuraminidase inhibitors, which inhibit viral release from the infected cell, are currently the only approved drugs for influenza, but have recently been shown to be less effective than previously thought. Growing resistance to therapies that target viral proteins has led to increased urgency in the search for novel anti-influenza compounds. However, discovery and development of new drugs have been restricted because of differences in susceptibility to influenza between animal models and humans and a lack of translation between cell culture and in vivo measures of efficacy. To circumvent these limitations, we developed an experimental approach based on ex vivo infection of human bronchial tissue explants and optimized a method of flow cytometric analysis to directly quantify infection rates in bronchial epithelial tissues. This allowed testing of the effectiveness of TVB024, a vATPase inhibitor that inhibits viral replication rather than virus release, and to compare efficacy with the current frontline neuraminidase inhibitor, oseltamivir. The study showed that the vATPase inhibitor completely abrogated epithelial cell infection, virus shedding, and the associated induction of proinflammatory mediators, whereas oseltamivir was only partially effective at reducing these mediators and ineffective against innate responses. We propose, therefore, that this explant model could be used to predict the efficacy of novel anti-influenza compounds targeting diverse stages of the viral replication cycle, thereby complementing animal models and facilitating progression of new drugs into clinical trials.<\/jats:p>","DOI":"10.4049\/jimmunol.1402283","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T01:32:28Z","timestamp":1430530348000},"page":"6144-6154","source":"Crossref","is-referenced-by-count":50,"title":["A Novel Lung Explant Model for the Ex Vivo Study of Efficacy and Mechanisms of Anti-Influenza Drugs"],"prefix":"10.1093","volume":"194","author":[{"given":"Ben","family":"Nicholas","sequence":"first","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J","family":"Staples","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Moese","sequence":"additional","affiliation":[{"name":"3-V Biosciences , Menlo Park, CA 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Meldrum","sequence":"additional","affiliation":[{"name":"3-V Biosciences , Menlo Park, CA 94025"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Ward","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dennison","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Havelock","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S C","family":"Hinks","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Amer","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Chamberlain","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"North","sequence":"additional","affiliation":[{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy","family":"Pink","sequence":"additional","affiliation":[{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M A","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratko","family":"Djukanovi\u0107","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Sir Henry Wellcome Laboratories, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]},{"name":"Southampton National Institute for Health Research Respiratory Biomedical Research Unit, Southampton General Hospital , Southampton SO16 6YD ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,15]]},"reference":[{"key":"2025030706552771400_r1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev.med.51.1.407","article-title":"Global epidemiology of influenza: past and present","volume":"51","author":"Cox","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"2025030706552771400_r2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(97)07468-0","article-title":"Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma","volume":"351","author":"Nicholson","year":"1998","journal-title":"Lancet"},{"key":"2025030706552771400_r3","first-page":"1","article-title":"Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"58","author":"National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Recomm."},{"key":"2025030706552771400_r4","first-page":"5","article-title":"Occasional review: influenza in COPD: pathogenesis, prevention, and treatment","volume":"2","author":"Wesseling","year":"2007","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"2025030706552771400_r5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0031-1283278","article-title":"Influenza: epidemiology, clinical features, therapy, and prevention","volume":"32","author":"Clark","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"2025030706552771400_r6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0031-1283281","article-title":"Influenza drug resistance","volume":"32","author":"Pizzorno","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"2025030706552771400_r7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jinf.2010.10.003","article-title":"Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review","volume":"62","author":"Jackson","year":"2011","journal-title":"J. Infect."},{"key":"2025030706552771400_r8","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"2025030706552771400_r9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature07151","article-title":"Drosophila RNAi screen identifies host genes important for influenza virus replication","volume":"454","author":"Hao","year":"2008","journal-title":"Nature"},{"key":"2025030706552771400_r10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature08760","article-title":"Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication","volume":"463","author":"Karlas","year":"2010","journal-title":"Nature"},{"key":"2025030706552771400_r11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature08699","article-title":"Human host factors required for influenza virus replication","volume":"463","author":"K\u00f6nig","year":"2010","journal-title":"Nature"},{"key":"2025030706552771400_r12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cell.2009.12.018","article-title":"A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection","volume":"139","author":"Shapira","year":"2009","journal-title":"Cell"},{"key":"2025030706552771400_r13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.virol.2009.02.046","article-title":"The use of random homozygous gene perturbation to identify novel host-oriented targets for influenza","volume":"387","author":"Sui","year":"2009","journal-title":"Virology"},{"key":"2025030706552771400_r14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chom.2010.05.008","article-title":"Cellular networks involved in the influenza virus life cycle","volume":"7","author":"Watanabe","year":"2010","journal-title":"Cell Host Microbe"},{"key":"2025030706552771400_r15","doi-asserted-by":"crossref","first-page":"A110","DOI":"10.1016\/j.antiviral.2008.12.014","article-title":"Animal models for the study of influenza pathogenesis and therapy","volume":"82","author":"Barnard","year":"2009","journal-title":"Antiviral Res."},{"key":"2025030706552771400_r16","first-page":"151","article-title":"The role of cytokines in the immune response to influenza A virus infection","volume":"50","author":"Sl\u00e1dkov\u00e1","year":"2006","journal-title":"Acta Virol."},{"key":"2025030706552771400_r17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/ajrccm\/143.4_Pt_1.772","article-title":"The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma","volume":"143","author":"Djukanovi\u0107","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"2025030706552771400_r18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1183\/09031936.00075612","article-title":"Barrier responses of human bronchial epithelial cells to grass pollen exposure","volume":"42","author":"Blume","year":"2013","journal-title":"Eur. Respir. J."},{"key":"2025030706552771400_r19","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.4049\/jimmunol.0901342","article-title":"Chemokine receptor 4 plays a key role in T cell recruitment into the airways of asthmatic patients","volume":"184","author":"Vijayanand","year":"2010","journal-title":"J. Immunol."},{"key":"2025030706552771400_r20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1165\/ajrcmb.25.3.4437","article-title":"The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma","volume":"25","author":"Richter","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2025030706552771400_r21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.RES.80.2.149","article-title":"Inhibition of stimulus-induced endothelial cell intercellular adhesion molecule-1, E-selectin, and vascular cellular adhesion molecule-1 expression by arachidonic acid and its hydroxy and hydroperoxy derivatives","volume":"80","author":"Huang","year":"1997","journal-title":"Circ. Res."},{"key":"2025030706552771400_r22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.169.1.407","article-title":"Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells","volume":"169","author":"Lordan","year":"2002","journal-title":"J. Immunol."},{"key":"2025030706552771400_r23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10520299309105629","article-title":"Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies","volume":"68","author":"Britten","year":"1993","journal-title":"Biotech. Histochem."},{"key":"2025030706552771400_r24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1165\/rcmb.4715","article-title":"Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium","volume":"28","author":"Puddicombe","year":"2003","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2025030706552771400_r25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4049\/jimmunol.164.1.412","article-title":"Role of B7-CD28\/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES","volume":"164","author":"Hidi","year":"2000","journal-title":"J. Immunol."},{"key":"2025030706552771400_r26","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1067\/mai.2002.130049","article-title":"Differential roles of IL-16 and CD28\/B7 costimulation in the generation of T-lymphocyte chemotactic activity in the bronchial mucosa of mild and moderate asthmatic individuals","volume":"110","author":"Dent","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025030706552771400_r27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa064691","article-title":"Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease","volume":"356","author":"Vijayanand","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"2025030706552771400_r28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1242\/jeb.024067","article-title":"Inhibitors of V-ATPases: old and new players","volume":"212","author":"Huss","year":"2009","journal-title":"J. Exp. Biol."},{"key":"2025030706552771400_r29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1743-422X-7-38","article-title":"Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution","volume":"7","author":"Van Poucke","year":"2010","journal-title":"Virol. J."},{"key":"2025030706552771400_r30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.virol.2009.10.016","article-title":"Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model","volume":"396","author":"Wu","year":"2010","journal-title":"Virology"},{"key":"2025030706552771400_r31","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1073\/pnas.1111179108","article-title":"Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak","volume":"108","author":"Sheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030706552771400_r32","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1086\/652498","article-title":"End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease","volume":"201","author":"Ison","year":"2010","journal-title":"J. Infect. Dis."},{"key":"2025030706552771400_r33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/path.2417","article-title":"Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients","volume":"216","author":"Deng","year":"2008","journal-title":"J. Pathol."},{"key":"2025030706552771400_r34","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/v2020566","article-title":"A host of factors regulating influenza virus replication","volume":"2","author":"Mehle","year":"2010","journal-title":"Viruses"},{"key":"2025030706552771400_r35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.109.162149","article-title":"Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells","volume":"333","author":"Yamaya","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025030706552771400_r36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0166-3542(95)00040-S","article-title":"Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells","volume":"27","author":"Ochiai","year":"1995","journal-title":"Antiviral Res."},{"key":"2025030706552771400_r37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jeb.200.1.1","article-title":"Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases","volume":"200","author":"Dr\u00f6se","year":"1997","journal-title":"J. Exp. Biol."},{"key":"2025030706552771400_r38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijantimicag.2010.01.006","article-title":"Treatment options for 2009 H1N1 influenza: evaluation of the published evidence","volume":"35","author":"Falagas","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2025030706552771400_r39","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/12\/6144\/62234722\/1402283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/194\/12\/6144\/62234722\/1402283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:36:05Z","timestamp":1741332965000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/194\/12\/6144\/7961021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,6,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1402283","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,6]]}}}